HOME › DRUGS › EFGARTIGIMOD ALFA
ACTIVE SUBSTANCE / INN

EFGARTIGIMOD ALFA

Brand name(s): VYVGART, Vyvgart
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
Myasthenia Gravis;Polyradiculoneuropathy, Chronic Inflammato…
BLA761195
ACTIVE SUBSTANCE
Efgartigimod Alfa
REGULATORS
FDA · EMA
SPONSORS / MAH
Argenx, ARGENX BV
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
VYVGARTBLA761195ARGENX BVPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
VyvgartArgenxAuthorised10/08/2022Myasthenia Gravis;Polyradiculoneuropathy, Chronic Inflammatory Demyelinating

FULL INTELLIGENCE ON EFGARTIGIMOD ALFA

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →